Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A polyepitope DNA vaccine targeted to Her-2/ErbB-2 elicits a broad range of human and murine CTL effectors to protect against tumor challenge.
Scardino A, Alimandi M, Correale P, Smith SG, Bei R, Firat H, Cusi MG, Faure O, Graf-Dubois S, Cencioni G, Marrocco J, Chouaib S, Lemonnier FA, Jackson AM, Kosmatopoulos K. Scardino A, et al. Among authors: firat h. Cancer Res. 2007 Jul 15;67(14):7028-36. doi: 10.1158/0008-5472.CAN-06-3998. Cancer Res. 2007. PMID: 17638916
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy.
Gross DA, Graff-Dubois S, Opolon P, Cornet S, Alves P, Bennaceur-Griscelli A, Faure O, Guillaume P, Firat H, Chouaib S, Lemonnier FA, Davoust J, Miconnet I, Vonderheide RH, Kosmatopoulos K. Gross DA, et al. Among authors: firat h. J Clin Invest. 2004 Feb;113(3):425-33. doi: 10.1172/JCI19418. J Clin Invest. 2004. PMID: 14755339 Free PMC article.
Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumors.
Scardino A, Alves P, Gross DA, Tourdot S, Graff-Dubois S, Angevin E, Firat H, Chouaib S, Lemonnier F, Nadler LM, Cardoso AA, Kosmatopoulos K. Scardino A, et al. Among authors: firat h. Eur J Immunol. 2001 Nov;31(11):3261-70. doi: 10.1002/1521-4141(200111)31:11<3261::aid-immu3261>3.0.co;2-4. Eur J Immunol. 2001. PMID: 11745343 Free article.
Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice.
Firat H, Tourdot S, Ureta-Vidal A, Scardino A, Suhrbier A, Buseyne F, Rivìere Y, Danos O, Michel ML, Kosmatopoulos K, Lemonnier FA. Firat H, et al. Eur J Immunol. 2001 Oct;31(10):3064-74. doi: 10.1002/1521-4141(2001010)31:10<3064::aid-immu3064>3.0.co;2-l. Eur J Immunol. 2001. PMID: 11592083 Free article.
H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies.
Firat H, Garcia-Pons F, Tourdot S, Pascolo S, Scardino A, Garcia Z, Michel ML, Jack RW, Jung G, Kosmatopoulos K, Mateo L, Suhrbier A, Lemonnier FA, Langlade-Demoyen P. Firat H, et al. Eur J Immunol. 1999 Oct;29(10):3112-21. doi: 10.1002/(SICI)1521-4141(199910)29:10<3112::AID-IMMU3112>3.0.CO;2-Q. Eur J Immunol. 1999. PMID: 10540322 Free article.
An HLA-A2 polyepitope vaccine for melanoma immunotherapy.
Mateo L, Gardner J, Chen Q, Schmidt C, Down M, Elliott SL, Pye SJ, Firat H, Lemonnier FA, Cebon J, Suhrbier A. Mateo L, et al. Among authors: firat h. J Immunol. 1999 Oct 1;163(7):4058-63. J Immunol. 1999. PMID: 10491010
125 results